SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mikey who wrote (732)3/7/1998 12:07:00 AM
From: Michael Paul Langley  Read Replies (1) of 1055
 
Correct, but I believe the many momentum players in THRX will also be looking at the sequential earnings also from the previous Q which will probably be flat or slightly down ($.18-.22). I am assuming that last Q was at near 100% capacity. The only negative I can find for THRX is their current capacity restraints with 4 cyclos operating when they could probably sell many more seeds if they were available. I wonder if THRX can maintain its 40% or so gross margins going forward? Looking forward to when THRX releases next Q earnings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext